Skip to search formSkip to main contentSkip to account menu

terazosin hydrochloride

Known as: Terazosin Hydrochloride Dihydrate, terazosin hcl, terazosin, monohydrochloride, dihydrate 
The hydrochloride salt form of terazosin, a quinazoline derivative with adrenergic antagonistic property. Terazosin hydrochloride selectively… 
National Institutes of Health

Related topics

Related topics

11 relations
Adrenergic alpha-Antagonists [MoA]Arterial Vasodilation [PE]Decreased Blood Pressure [PE]Drug Allergy

Narrower (1)

Hytrin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Rayleigh light scattering detection of three α1-adrenoceptor antagonists coupled with high performance liquid chromatograph.
2013
2013
Thermoanalytical investigation of terazosin hydrochloride.
PURPOSE Thermal analysis (TGA, DTG and DTA) and differential scanning calorimetry (DSC) have been used to study the thermal… 
2011
2011
Pharmacokinetic and Pharmacodynamic Study of Terazosin in HealthyChinese Volunteers: Significant Hysteresis Phenomenon
Aim: The present study investigated the correlation between plasma concentration and antihypertensive effect of terazosin in… 
2006
2006
Identification, preparation, and characterization of several polymorphs and solvates of terazosin hydrochloride.
The phenomenon of polymorphism is prevalent in pharmaceuticals, yet it is unusual to identify more than three or four forms for… 
2004
2004
1356: Concomitant Use of Sildenafil With Tamsulosin or Terazosin - A Retrospective Safety Evaluation
2000
2000
Transdermal drug delivery using electroporation. I. Factors influencing in vitro delivery of terazosin hydrochloride in hairless rats.
The use of electroporation pulses as a physical means of enhancing the permeability of skin to deliver drugs is in the early… 
2000
2000
Transdermal drug delivery using electroporation. II. Factors influencing skin reversibility in electroporative delivery of terazosin hydrochloride in hairless rats.
A previous study indicated that the parameters governing the performance of electroporative delivery to the skin, are voltage… 
1996
1996
A cost density analysis of benign prostatic hyperplasia.
1992
1992
[A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy].
In this study the multicenter, fixed-flexible dose regimen was taken to evaluate the effective dose range of Terazosin for the… 
Highly Cited
1983
Highly Cited
1983
Long-term BP monitoring in the evaluation of antihypertensive therapy.
Noninvasive BP monitoring was performed in hypertensive patients before and during placebo therapy and before and during therapy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)